Neurosense Therapeutics Ltd
NRSNW
Ver gráfico detallado
0.440USD
+0.090+25.61%
Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Hoy
+25.61%
5 Días
+4.19%
1 Mes
-36.23%
6 Meses
+112.56%
Año hasta la fecha
0.00%
Un año
+158.98%
Ver gráfico detallado
Puntuación de acciones TradingKey
Sin datos de puntuación
Noticias
Próximamente más noticias, permanezca atento...
Indicadores financieros
BPA
Sin datos
Ingresos totales
Sin datos
Compañía
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Símbolo de cotizaciónNRSNW
CompañíaNeurosense Therapeutics Ltd
Director ejecutivoMr. Alon Ben-Noon
Sitio Webhttps://www.neurosense-tx.com/
Instrumentos Relacionados
+0.68%
+1.38%
-2.48%
-1.57%
-0.75%
-0.09%
+1.34%
-1.77%
-0.67%
-3.03%
-0.85%
-0.87%
-0.50%
+0.44%
-0.19%
-1.18%
-2.84%
0.00%
+0.30%
-3.72%
